All In Biotech

Drug Trial Radar · NCT03852654

18F-DCFPyL PET-CT Scan and Prostate Cancer

A Novel 18F-DCFPyL PET-CT Scan for Diagnosis and Management of Prostate Cancer

Last checked: Nov 19, 2026Latest source record: Feb 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

170

Planned (sponsor's estimate)

Start

Jul 22, 2018

Primary completion

Dec 30, 2019

Study completion Jun 30, 2020

Sponsor

Lead sponsor
Lida JafariFederal agency
Sponsor type
Federal agency
Collaborators
University of California, Los Angeles
First posted
Feb 25, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary Objective: The primary objective of this study is to assess the efficacy of 18F-DCFPyL PET-CT for initial staging of prostate cancer in Veterans compared to conventional imaging (99mTc-MDP bone scan and Diagnostic CT or MRI). The primary clinical endpoint of our study is the percent of Veterans with prostate cancer in which the 18F-DCFPyL PET-CT identifies M1 disease at initial staging. Secondary Objectives: Frequency of the change in primary treatment plan after initial staging.

Conditions

  • Prostate Cancer Adenocarcinoma

Interventions

  • 18F-DCFPyLDrug

    Subjects with biopsy proven prostate cancer, no prior local therapy, and: PSA ≥ 10 ng/dl, or Gleason Sum ≥ 4+3, or clinical stage ≥cT2c Staging by 99mTc-MDP or NaF PET bone scan, and Diagnostic CT (pelvis) or MRI will undergo 18F DCFPyL PET CT scan.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the percent of Veterans with prostate cancer in which the 18F-DCFPyL PET-CT identifies M1 disease at initial stagingTime frame: 120 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • VA Greater Los Angeles

    Los Angeles, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.